Evidence map›Paper›PMID 37341072›Full record

ArticleCNS neuroscience & therapeutics2024

Effects of heterologous human tau protein expression in yeast models of proteotoxic stress response.

Klara Zubčić, Dina Franić, Mihaela Pravica, Patrick R Hof, Goran Šimić, Mirta Boban

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Klara ZubčićCroatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Dina FranićCroatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Mihaela PravicaCroatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Patrick R HofNash Family Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Goran ŠimićCroatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.ORCID 0000-0002-6339-9261
Mirta BobanCroatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.ORCID 0009-0000-9493-3917
University of Zagreb · HRAllen Institute for Brain Science · US

Funding

Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Carolyn Wei Zhu · 2020 to 2026
$31.0M
CoRE-NeuroCroatian Science Foundation IP-2014-09-9730Croatian Science Foundation IP-2019-04-3584EUEuropean Regional Development FundEuropean Social FundNIA NIH HHS P30 AG066514Operational Program Competitiveness and Cohesion KK.01.1.1.01.0007Operational Program Efficient Human Resources 2014-2020Research Cooperability Program of the Croatian Science Foundation DOK-2018-01-9299Research Cooperability Program of the Croatian Science Foundation DOK-2021-02-2505Research Cooperability Program of the Croatian Science Foundation PZS-2019-02-3610
6 · The paper itself

Abstract

backgroundThe primary histological characteristic of Alzheimer's disease is the presence of neurofibrillary tangles, which are large aggregates of tau protein. Aging is the primary risk factor for the development of Alzheimer's disease, however, the underlying causes of tau protein aggregation and toxicity are unclear.

aimsHere we investigated tau aggregation and toxicity under the conditions of compromised protein homeostasis.

methodsWe used heterologous expression of human tau protein in the unicellular eukaryote yeast Saccharomyces cerevisiae with evolutionarily conserved protein quality control pathways and examined tau-dependent toxicity and aggregation using growth assays, fluorescence microscopy, and a split luciferase-based reporter NanoBiT.

resultsTau protein expressed in yeast under mild proteotoxic stress, or in mutants with impaired pathways for proteotoxic stress response, did not lead to synthetic toxicity or the formation of obvious aggregates. Chronologically old cells also did not develop observable tau aggregates. Our examination of tau oligomerization in living cells using NanoBiT reporter suggests that tau does not form significant levels of oligomers under basal conditions or under mild proteotoxic stress.

conclusionTogether our data suggest that human tau protein does not represent a major burden to the protein quality control system in yeast cells.

Indexed as

Saccharomyces cerevisiaetau ProteinsHumansProteotoxic StressStress, PhysiologicalMAPT protein, humantau Proteinschronological agingproteasomeprotein aggregationprotein homeostasisprotein interaction assayprotein quality controltoxicityyeast

Identifiers

PMID37341072
PMCPMC11163194
OpenAlexW4381469754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.